Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse AI-driven companies

Explore AI-driven private companies. 

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (2)
More (2)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Xaira TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$1BSeries A4/23/2024$500MM$2.65B$2.50ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, Rsquared, SV Angel
InsitroHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$1.26BSeries C3/15/2021$400MM$2.57B$18.29CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank
Formation BioHealthcare
Biotech & Pharma		Low$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$3.38BSeries D6/26/2024$372MM$1.48B$8.18Andreessen Horowitz, Sanofi, Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, SV Angel Growth, FPV Ventures
OwkinHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$279.77MMSeries B-16/8/2022$50MM$1.46B$45.70Bristol Myers Squibb
SynthegoHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$415.07MMSeries E2/17/2022$144.17MM$1.3B$10.78Perceptive Advisors, SoftBank, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund, Chimera Abu Dhabi, Wellington Management, RA Capital Management, Moore Strategic Ventures
AsimovHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$241.8MMSeries B1/5/2023$175MM$1.24B$92.68CPP Investments, Fidelity, KDT, Casdin Capital, Pillar, Andreessen Horowitz, Horizons Ventures
ImmunaiHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$295.22MMSeries C-110/27/2021$204.34MM$1.15B$186.65Koch Disruptive Technologies, Talos VC, 8VC, Alexanria Venture Investments, Piedmont, ICON
Harbinger HealthHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$470.04MMSeries B-12/20/2025$289.97MM$781.26MM$6.60Undisclosed Investors
InterVennHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$245.77MMSeries C8/2/2021$201.27MM$685.15MM$8.83A.G. Hill Partners, Amplify Partners, Anzu Partners, Genoa Ventures, Heritage Provider Network, Highside Capital Management, Irving Investors, Softbank Group, True Ventures
Dyno TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$111MMSeries A5/6/2021$100MM$539.27MM$44.66Andreessen Horowitz, Casdin Capital, GV, Obvious Ventures, Lux Capital
Genesis TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$308.66MMSeries B8/10/2023$200MM$430.19MM$5.11Andreessen Horowtiz, Fidelity, BlackRock, Nventures, T. Rowe Price Associates, Rock Springs Capital, Radical Ventures, Menlo Ventures
ArteraAIHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$97.32MMSeries Seed-32/1/2024$82.82MM$408.31MM$7.95Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst, TIME Ventures, Breyer Capital, The Factory, Marc Benioff, Jim Breyer, Lip-Bu Tan, Chris Re, Andy Jacques, Amarjit Gill, Jeff Dean, Steve Blank, Dennis Wong, Clarence So, Michael Driscoll, Prosperity7 Ventures, EDBI, Wilson Sonsini Goodrich & Rosati, Trium Ventures, Navin Chaddha, Rajiv Khemani, Andrew Tan, Elliott Tan
Verge GenomicsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$167.53MMSeries C*9/8/2023$42MM$403.75MM$7.19Alexion, AstraZeneca, Alumni Ventures, Tenmile
Clear LabsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$157.08MMSeries D1/13/2025$30MM$395.17MM$2.80Counterpoint Global, Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, T. Rowe Price Associates
Terray TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$201.97MMSeries B10/17/2024$120MM$386.49MM$6.66Bedford Ridge Capital, NVIDIA, Maverick Capital, Goldcrest Capital, Madrona Venture Group, Two Sigma Ventures, XTX Ventures, Digitalis Ventures, Alexandria Venture Investments
BigHat BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$104.3MMSeries B7/20/2022$80MM$249.63MM$9.24Section 32, Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, GRIDS Capital, Andreessen Horowitz, 8VC, AME Cloud Ventures
Numerion LabsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$132.26MMSeries D3/10/2026$19.79MM$122.5MM$0.37Undisclosed Investors
Moonwalk BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
1-18 of 18

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.